JMBM’s Mergers & Acquisitions Group Closes $45 Million Financing for Private Equity Firm NAXOS Capital Partners
Investment in Clean Tech Sector
LOS ANGELES – May 4, 2011. Jeffer Mangels Butler & Mitchell LLP (JMBM) represented lead investor NAXOS Capital Partners in the recent $45 million growth equity financing of BioAmber Inc. Attorneys on the JMBM team included David B. Stern and Rod Berman.
This is the second deal where JMBM has represented NAXOS in the clean tech arena. JMBM also represented NAXOS as the lead investor in the $100 million Series C financing in Elevance Renewable Sciences Inc., one of the largest US venture capital investment deals in Q4 2010 in the Industry Products and Services segment of “Clean Tech”, according to Ernst & Young, LLP.
“Both BioAmber and Elevance focus their businesses on sophisticated technologies involving chemical engineering, catalysts, yeasts and bacteria,” said Rod S. Berman, Chair of JMBM’s Intellectual Property Group. “Our technical background in these technologies and our depth of intellectual property experience in this area made these deals a perfect fit for us.”
The deal closed on April 15, 2011 and was announced by BioAmber on May 4, 2011.
About JMBM’s Mergers & Acquisitions Group
JMBM’s Mergers & Acquisitions Group represents buyers, sellers and capital providers in a wide variety of mergers, acquisitions, divestitures and financings. Our lawyers provide start-to-finish assistance with the structuring, negotiation, documentation and closing of the deal, using the firm’s full resources for everything from intellectual property issues to tax-efficient deal structures.
About NAXOS Capital Partners
NAXOS Capital Partners is a Luxembourg-based private equity group focused on acquiring and developing small- to lower and mid-market companies with unique intellectual property or market positions in renewable chemistry and energy.